InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
TrueTrades Free
02/20/15 10:29 AM
profile icon
TrueTrades Free
02/15/15 7:07 PM
profile icon
Touktouk Free
02/15/15 6:50 PM
profile icon
TrueTrades Free
02/14/15 7:13 PM
profile icon
TrueTrades Free
02/14/15 5:34 PM
profile icon
Touktouk Free
02/14/15 4:50 PM
profile icon
TrueTrades Free
01/26/15 7:18 PM
profile icon
TrueTrades Free
01/04/15 1:38 AM
profile icon
stocktrademan Free
11/26/14 10:06 AM

Liminal Biosciences Inc (LMNL) RSS Feed

Followers
14
Posters
31
Posts (Today)
0
Posts (Total)
60
Created
11/26/14
Type
Free
Moderators
ProMetic Life Sciences Inc. 531 Des Prairies Boulevard Building 15 Laval, QC H7V 1B7 Canada Phone: 450-781-0115 Fax: 450-781-4477 Website: http://www.prometic.com ProMetic Life Sciences Inc., a biopharmaceutical company, develops bioseparation, plasma-derived therapeutics, and small-molecule drugs. The company also offers its technologies for large-scale drug purification, drug development, proteomics, and the elimination of pathogens; and develops small molecule therapeutics products targeting unmet medical needs in the fields of fibrosis, anemia, cancer, and autoimmune disease, as well as plasma-derived therapeutics in orphan drug indications. It operates in two segments, Therapeutics and Protein Technology. The Therapeutics segment’s lead product includes PBI-4050, which targets unmet medical needs, such as the treatment of fibrosis in patients with chronic kidney diseases and certain cancers, and the side effects associated with chemotherapy. This segment also develops PBI-4419, an anti-fibrotic and anti-inflammatory compound for kidney injury and chronic kidney diseases; and PBI-1402, a drug candidate for the treatment of anemia indications. The Protein Technology segment provides plasma protein purification system, a solution for the extraction and purification of therapeutic proteins from human plasma; bioseparation products based on applications of its patented Mimetic Ligand technology for various biopharmaceutical companies; and prion capture/pathogen removal technology platform that improves the safety profile of blood products and blood-derived therapeutics. The company was formerly known as Innovon Life Sciences Holdings Limited and changed its name to ProMetic Life Sciences Inc. in May 1998. ProMetic Life Sciences Inc. was founded in 1992 and is headquartered in Laval, Canada.
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
LMNL Latest News
  • No Recent News Available for this company!
New Post